Follow-The-Filings

INM InMed Pharmaceuticals

InMed Pharmaceuticals earnings company data as of 4:46 AM ET 9/3

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q2 28 Sep EPS
Rev

SEC filings

Recent issuer filings from EDGAR · 22 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01
8-K 1.01,7.01,9.01
8-K 8.01,9.01
8-K 1.01,3.03,8.01,9.01
8-K 1.01,5.01,5.02,7.01,9.01
8-K 7.01,9.01
10-Q QUARTERLY REPORT
8-K 1.01,3.03,8.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
8-K 3.01,9.01
8-K 7.01,9.01
8-K 7.01,9.01
8-K 2.05,7.01,9.01
8-K 7.01,9.01
10-Q QUARTERLY REPORT
8-K 5.07,7.01,9.01
8-K 8.01,9.01
8-K 7.01,9.01
10-Q QUARTERLY REPORT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
10-K/A AMENDMENT NO. 1 TO FORM 10-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Jul 15, 2026
4 Period Jul 14, 2026
4 Period Jun 30, 2026
4 Period May 20, 2026
4 Period May 19, 2026

13 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice